3 terminated. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
| Phase 2 | 2 | Terminated 2 |
Follow Cholangitis: new trials by email Literature Review of Cholangitis trials Research Report on Cholangitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vancomycin for Primary Sclerosing Cholangitis Vancomycin, Placebo - Primary Sclerosing Cholangitis | Phase 2 / Phase 3 | Terminated | Elizabeth Carey | 102 | 2020-01-23 | 2026-10-21 |
| Study of Cilofexor in Adults With Primary Sclerosing Cholangitis Cilofexor, Placebo - Primary Sclerosing Cholangitis | Phase 3 | Terminated | Gilead Sciences | 419 | 2019-03-27 | 2023-11-29 |
| Trial of High-dose Urso in Primary Sclerosing Cholangitis Ursodeoxycholic Acid, Placebo - Primary Sclerosing Cholangitis | Phase 2 / Phase 3 | Terminated | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 150 | 2002-07-01 | 2021-05-03 |
Bile Duct Diseases (3) · Biliary Tract Diseases (3) · Digestive System Diseases (3)
Ursodeoxycholic Acid (1) · Vancomycin (1) · cilofexor (1)
Elizabeth Carey (1) · Gilead Sciences (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
United States (3) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1) · New Zealand (1) · Spain (1) · Switzerland (1)
PMID 19585548, PMID 41173015, PMID 42489629
2019 (1), R01DK056924 (1)